References
- Martindale, The Extra Pharmacopoeia, J. E. F. Reynolds. The Pharmaceutical Press, London 1993
- Lott R. S. Seizure disorders. Applied Therapeutics. The Clinical Use of Drugs, L. Y. Young, M. A. Koda-Kimble. Applied Therapeutics, Washington 1990; 1369–1396
- Mattila M. A. K., Suistomaa M. Intravenous premedication with diazepam. Anaesthesia 1984; 39: 879
- Langdon D. E. Thrombophlebitis following diazepam. JAMA 1973; 225: 1389
- Florence A. T., Attwood D. Drug interactions and incompatibilities—A physicochemical view. Physico-chemical Principles of Pharmacy, A. T. Florence, D. Attwood. Macmillan Press, HoundmillsUK 1988; 407–454
- Chien Y. W. Nasal drug delivery and delivery systems. Novel Drug Delivery Systems2nd ed., Y. W. Chien. Marcel Dekker, New York 1994; 229–268
- Chien Y. W., Chang S.-F. Intranasal drug delivery for systemic medication. Crit. Rev. Ther. Carrier Syst. 1987; 4: 67–194
- Gizurarson S. The relevance of nasal physiology to the design of drug absorption studies. Adv. Drug Deliv. Rev. 1993; 11: 329–347
- Wilton N. C. T., Leigh J., Rosen D. R., Pandit U. A. Preanesthetic sedation of preschool children using intranasal midazolam. Anesthesiology 1988; 69: 972–975
- Louon A., Reddy V. G. Nasal midazolam and ketamine for paediatric sedation during computerised tomography. Acta Anesthesiol. Scand. 1994; 38: 259–261
- Lui C. Y., Amidon G. L., Goldberg A. Intranasal absorption of flurazepam, midazolam, and triazolam in dogs. J. Pharm. Sci. 1991; 80: 1125–1129
- Gouldberg A. H. Nasal administration of benzodiazepine hypnotics, Eur. Patent Application no. 0386232B1
- Lau S. W. J., Slattery J. T. Absorption of diazepam and lorazepam following intranasal administration. Int. J. Pharm. 1989; 54: 171–174
- Schols-Hendriks M. W. G., Lohman J. J. H. M., Janknegt R., Korten J. J., Merkus F. W. H. M., Hooymans P. M. Absorption of clonazepam after intranasal and buccal administration. Br. J. Clin. Pharmac 1995; 39: 449–451
- Spiegelberg H., Schläpfer R., Zbinden G., Studer A. Ein neues injizierbares lösnungsmittel (Glycofurol). Arzneittelforschung 1956; 6: 75
- Bechgaard E., Gizurarson S., Hjortkjær R. K. A pharmaceutical preparation, Patent no. PCT/DK91/00119, 1991
- Taubøll E., Lindstrom S., Klem W., Gjerstad L. A new injectable carbamazepine solution—antiepileptic effects and pharmaceutical properties. Epilepsy Res. 1990; 7: 59–64
- Alessandri M. G., Scalori V., Giovannini L., Mian M., Bertelli A. A. E. Plasma and tissue concentration of Coenzyme Q10 in the rat after intravenous administration by a microsphere delivery system or in a new type of solution. Int. J. Tissue Reac 1988; X: 99–102
- Bury R. W., Breen K. J., Desmond P. V., Raymond K., Mashford M. L. Disposition of intravenous glycofurol: effect of hepatic cirrhosis. Clin. Pharm. Ther. 1984; 36: 82